Related Experiment Video
Updated: Apr 21, 2026

A Personalized 3D-Printed Model for Preoperative Evaluation in Thyroid Surgery
Published on: February 17, 2023
Development and Validation of a Predictive Model for Postoperative Nausea and Vomiting in Thyroid Cancer Patients: A
Fangfang Li1, Zifeng Li2, Shengmei Wu3
1Department of Thyroid and Breast Surgery, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People's Hospital, Yichang, People's Republic of China.
This study identifies key risk factors for postoperative nausea and vomiting (PONV) in thyroid cancer patients, developing a predictive model to aid clinical management and improve patient outcomes after surgery.
Area of Science:
- Endocrinology
- Surgical Oncology
- Anesthesiology
Background:
- Thyroid cancer is the most common endocrine malignancy, with surgery as the primary treatment.
- Postoperative nausea and vomiting (PONV) frequently complicates thyroid surgery, impacting recovery.
- Identifying PONV risk factors is crucial for effective patient management.
Purpose of the Study:
- Analyze risk factors for PONV in post-thyroid cancer surgery patients.
- Develop and validate a predictive model for PONV.
- Enhance clinical decision-making for PONV prevention.
Main Methods:
- Retrospective study of 393 thyroid cancer patients.
- Multivariate logistic regression for model construction and nomogram development.
- Evaluation of model discrimination (ROC curves), calibration, and clinical utility (DCA).
Main Results:
- Overall PONV incidence was 29.01%.
- Predictive model included age (≥50), history of PONV/motion sickness, non-use of ondansetron, and delayed oral intake (>6 hours).
- Model showed good discrimination (AUC 0.76 training, 0.68 validation) and clinical applicability.
Conclusions:
- Age, prior PONV/motion sickness, ondansetron use, and delayed oral intake are significant PONV risk factors in thyroid cancer patients.
- The developed PONV prediction model demonstrates favorable discriminatory ability, calibration, and clinical utility.
- This model can assist clinicians in predicting and managing PONV risk post-thyroidectomy.
More Related Videos
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Pathophysiology of Vomiting

